The board of directors of Link-Asia International MedTech Group Limited announced, Ms. Bian Sulan has been appointed as an executive Director of the Company with effect from 12 June 2023. Ms. Bian, aged 55, has over 30 years of working experience in marketing, promotion and media business management. Before joining the Group, Ms. Bian worked as the general director of a company mainly engaged in social media business in the PRC, mainly responsible to manage the company's daily operations, including but not limited to marketing promotion, customer management, product sales and review of the company brand development.

She has extensive experience in sales planning, marketing management and wide personal networks in different industries. Mr. Yang Weidong has tendered his resignation as an independent non- executive Director and cease to be the member of the audit committee and nomination committee and the Chairman of the remuneration committee of the Company with effect from 12 June 2023 due to his own business commitment. Mr. Yang has confirmed that he has no disagreement with the Board and there are no others matters in respect of his resignation that need to be brought to the attention of the shareholders and the Stock Exchange.

The Board would like to express its sincere gratitude to Mr. Yang for his valuable contribution to the Company during his tenure of service. Following the resignation of Mr. Yang, the Board comprises seven members, including five executive Directors and two independent non-executive Director. The current number of independent non-executive Director is less than three as required under Rule 3.10(1) of the Listing Rules.

Mr. Yang was also the chairman of the Remuneration Committee, a member of the Nomination Committee and a member of Audit Committee of the Company. Following Mr. Yang's Resignation, the Board is unable to fulfil the requirement of having three members on the Audit Committee under Rule 3.21 of the Listing Rules.